Profile
Yoav Ben-Yaacov is the founder of KR36 Ltd.
(founded in 2005).
Mr. Ben-Yaacov is also the founder of CTG Pharma Ltd.
Yoav Ben-Yaacov active positions
| Companies | Position | Start |
|---|---|---|
KR36 Ltd.
 KR36 Ltd. Engineering & ConstructionIndustrial Services KR36 Ltd. provides energy saving solutions. The firm's products include air-conditioning, heating and ventilation systems to save energy consumption of software, physics, and control-oriented applications. Its customers include supermarkets, malls, industrial factories, hospitals and office buildings. The company was founded by Yoav Ben-Yaacov and Yaki Gidali in 2005 and is headquartered in Even Yehuda, Israel. | Founder | 2009-07-15 |
CTG Pharma Ltd.
 CTG Pharma Ltd. Pharmaceuticals: MajorHealth Technology CTG Pharma Ltd. operates in the pharmaceutical industry. It develops immunotherapy for cancer patients and provides biological solution to enable the use of CAR-T (Chimeric Antigen Receptors for T Cells) and TCR (T-cell receptor) therapies for solid tumors. The company was founded by Yoav Ben-Yaacov and is headquartered in Tel Aviv, Israel. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
KR36 Ltd.
KR36 Ltd. Engineering & ConstructionIndustrial Services KR36 Ltd. provides energy saving solutions. The firm's products include air-conditioning, heating and ventilation systems to save energy consumption of software, physics, and control-oriented applications. Its customers include supermarkets, malls, industrial factories, hospitals and office buildings. The company was founded by Yoav Ben-Yaacov and Yaki Gidali in 2005 and is headquartered in Even Yehuda, Israel. | Industrial Services |
CTG Pharma Ltd.
CTG Pharma Ltd. Pharmaceuticals: MajorHealth Technology CTG Pharma Ltd. operates in the pharmaceutical industry. It develops immunotherapy for cancer patients and provides biological solution to enable the use of CAR-T (Chimeric Antigen Receptors for T Cells) and TCR (T-cell receptor) therapies for solid tumors. The company was founded by Yoav Ben-Yaacov and is headquartered in Tel Aviv, Israel. | Health Technology |
- Stock Market
- Insiders
- Yoav Ben-Yaacov
